InVita Expands HemaConnect to Support Cell and Gene Therapy Donor Programs

April 23, 2026
InVita Healthcare Technologies and Gulf Coast Blood have introduced new capabilities in HemaConnect 2.5 to streamline donor recruitment and scheduling for cell and gene therapy programs.

InVita Healthcare Technologies and Gulf Coast Blood have introduced new advanced therapy capabilities in the latest HemaConnect 2.5 release, announced in a press release. The update enables blood centers to efficiently recruit, schedule, and track donors for specialized cell and gene therapy treatments.

Developed in collaboration between the two organizations, the new version includes configured profiles and workflows for therapy specific requirements, enhanced scheduling tools that connect interviews, sampling, and collections, and administrative features that coordinate traditional blood and advanced biotherapy collections.

The release aims to help blood centers use their existing donor networks to support regenerative medicine and other advanced treatments. HemaConnect currently supports most U.S. blood centers, managing millions of donor interactions each year through email, text, and call communications.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

04/23
OZMOSI and Planview Partner to Integrate AI Planning in Pharma R&D
04/23
SamaCare Releases Benchmarks for Medical Benefit Prior Authorization Performance
04/23
Independent Emergency Physicians Invests in ConsensioHealth
04/23
Avenda Health's Unfold AI Added to Medicare Fee Schedule Across Western States
04/23
Heidi Launches in South Africa with 15,000 Clinicians Already Using Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like